Why we need to focus on standardized treatment of cancer pain

Emphasis on standardized treatment of cancer pain According to survey statistics, 70% of cancer patients who visit hospitals are already in advanced stages, and pain is a problem that these patients need to solve. The World Health Organization has made cancer pain control one of the four priorities in its comprehensive plan to overcome cancer, and has set the goal of making cancer patients pain-free by the year 2000. However, cancer pain treatment is not as satisfactory as it should be. At present, there are still very few hospitals specializing in cancer pain treatment in China, which cannot meet the needs of pain patients at all. About 70% of patients at home and 60% of inpatients do not get enough pain relief, and many patients commit suicide because they cannot stand the pain. The reasons for this come from three main sources. On the one hand, patients or family members wrongly believe that pain relief may affect the fight against cancer; or they think that what is the use of pain relief? They may be reluctant to tell the doctor that the patient is in pain; or they may wrongly believe that pain is the inevitable result of disease and treatment; or they may be afraid of using strong analgesic drugs like morphine to relieve pain and become “addicted” to the drugs. On the other hand, oncologists are significantly under-educated in pain management; some specialists only focus on anti-cancer treatment and neglect pain management, and believe that pain is inevitable; it is unnecessary or uncontrollable, especially some doctors neglect patients’ residual post-operative pain, pain complicated by radiotherapy and chemotherapy, and pain unrelated to cancer. On the other hand, some people wrongly believe that the use of dulcolax is the most effective painkiller. In fact, the World Health Organization has listed Dulcolax as a non-recommended drug for cancer pain. The pain-relieving effect of Dulcolax is only one-tenth of morphine, and it can only be considered as a medium-strength painkiller. In addition, because of the poor absorption rate of oral dulcolax, it is mostly administered by intramuscular injection, and intramuscular injection itself can produce pain, so it is not suitable for chronic pain treatment such as cancer pain. Active control of cancer pain has important clinical significance. Eliminating or relieving cancer pain not only can make patients and family members reduce or eliminate pain, but also importantly can save patients’ immunity from being damaged or less damaged. Because the patients’ pain is eliminated, their mood is better, their meals smell better, their sleep is better, and their organism’s fighting power is strengthened again, they can better cooperate with anti-cancer treatment, thus delaying or inhibiting the continued spread or metastasis of tumor cells and prolonging the patients’ life span, and at the same time, it can also well improve the patients’ quality of life and life quality. For advanced cancer, pain control is the focus, which can be combined with immune enhancement therapy, and even mild or moderate pain should be treated actively. When treating pain, doctors should listen to and trust the patient’s complaints, and accurate pain assessment is the key to proper treatment. The treatment methods and procedures for advanced cancer pain are: 1. drug treatment; 2. neurohistoplasty; 3. patient-controlled analgesia (PCA); 4. nerve relaxation; 5. radiofrequency treatment; 6. spinal cord electrical stimulation or biological treatment; 7. general subanesthesia treatment, needle knife relaxation treatment. The principles of treatment are: daily pain assessment, timely administration of analgesia, combined or cyclic application of the above methods, together with psychotherapy. The objectives of treatment are: to eliminate pain in a sustained and lasting manner; to control adverse drug reactions; to minimize the psychological burden caused by pain and treatment; and to improve the quality of life to the minimum. In conclusion, cancer pain is the most complicated and difficult problem among all chronic pain treatments at present, due to different causes of pain, different nature of tumors, different scope of lesions, different sites of tumor metastasis, different nature of pain, different psychological states of patients, different ability of patients to pay medical expenses, different attitudes of patients and family members towards cancer pain treatment, different drugs and methods of analgesia, etc. All of them can affect the analgesic effect. As a specialist in cancer pain treatment, you should firmly believe that cancer pain can be satisfactorily controlled and convince every patient you treat of this. Most of the cancer pain can be easily controlled, but for the intractable severe pain, as a pain treatment specialist, you should build up strong confidence and adopt reasonable comprehensive treatment methods to achieve the purpose of pain control. With the development of society, people’s demand for quality of life and survival is increasing year by year, and the accelerated aging process of the population and the accelerated pace of life have led to a dramatic increase in the incidence of various types of chronic pain, and chronic intractable pain is seriously affecting people’s physical function and quality of life. Most of these diseases do not require open surgery, but oral medication alone is often ineffective or prone to recurrence. In particular, there are countless people whose pain is not relieved after long-term treatment. In order to change the above, our hospital has added “pain department” to our medical departments. What diseases can be treated in the pain department? Neck, shoulder, waist and leg pain, cervical spondylosis, cervical dizziness and headache, frozen shoulder, lumbar disc herniation, age-related knee pain, heel pain, chronic soft tissue injury, trigeminal neuralgia, postherpetic neuralgia, cancer pain, post-diabetic neuralgia, central pain, post-spinal cord injury pain, phantom limb pain, residual limb pain, post-brachial plexus nerve injury pain, linguopharyngeal neuralgia, sudden deafness, ischemic cardiovascular disease and menopausal syndrome, etc.